ライフサイエンスコーパス: glomerular filtration rate

1 0 3A5 genotype, pregraft sensitization, mo 3 glomerular filtration rate).

2 s occurring at the lowest baseline estimated glomerular filtration rate.

3 varies proportionally to the single-nephron glomerular filtration rate.

4 ge estimated from CKD-epidemiology estimated glomerular filtration rate.

5 were defined by >=50% decrease in estimated glomerular filtration rate.

6 independent predictor of PENK was estimated glomerular filtration rate.

7 lated to delayed graft function or estimated glomerular filtration rate.

8 eatinine, blood urea nitrogen, and estimated glomerular filtration rate.

9 t lymphoproliferative disease, and estimated glomerular filtration rate.

10 roalbumin-to-creatinine ratio, and estimated glomerular filtration rate.

11 oss racial/ethnic groups and the spectrum of glomerular filtration rates.

12 .16; 95% CI, 0.94-1.43; P = 0.16), estimated glomerular filtration rate 1-y posttransplant (B, 0.58;

13 . 1.73 m-2) and 192 participants in study B (glomerular filtration rate: 13-24 mL . min-1 . 1.73 m-2)

14 those with chronic kidney disease (estimated glomerular filtration rate 20-40 mL/min per 1.73 m(2)) a

15 older with chronic kidney disease (estimated glomerular filtration rate 25 to <=45 mL/min per 1.73 m(

16 el, >=7%), chronic kidney disease (estimated glomerular filtration rate, 25 to 60 ml per minute per 1

17 DRD) Study from 482 participants in study A (glomerular filtration rate: 25-55 mL . min-1 . 1.73 m-2)

18 lone, resulting in improvements in estimated glomerular filtration rate (31.5 +/- 16 versus 38.8 +/-

19 ble within 3 months before biopsy (estimated glomerular filtration rate, 55.3 +/- 18.9 mL/min/1.73 m)

20 , there were no differences in the estimated glomerular filtration rate (57.7 +/- 18.2 vs 56.3 +/- 17

21 D+ vs 92% D-, P = .9), 1-year mean estimated glomerular filtration rate (63 mL/min D+ vs 57 mL/min D-

22 3 months after LT in the SIR arm (estimated glomerular filtration rate 74 [57-95] versus 67 [55-85]

23 s age (selected in each of the 1000 splits), glomerular filtration rate (794 splits), diabetes (323 s

24 ellitus duration 11.0 [8.2] years, estimated glomerular filtration rate 88.4 [16.9] mL/min/1.73m(2),

25 m2 accompanied by >=25% decline in estimated glomerular filtration rate, a kidney disease-related hos

26 was performed among patients with estimated glomerular filtration rate above 60 ml/min/1.73 m(2) at

27 stics of previously suggested that estimated glomerular filtration rate-adjusted D-dimer cutoff level

28 k to validate previously suggested estimated glomerular filtration rate-adjusted D-dimer cutoff level

29 -positive rate can be reduced when estimated glomerular filtration rate-adjusted D-dimer cutoff level

30 type of renal dysfunction affects estimated glomerular filtration rate-adjusted D-dimer test charact

31 ssociated with kidney-related traits such as glomerular filtration rate, albuminuria, hypertension, e

32 ody mass index, blood pressure, or estimated glomerular filtration rate (all P for interaction >0.20)

33 have investigated the prevalence of reduced glomerular filtration rate and albuminuria in the Fontan

34 stages of albuminuria, leading to decline in glomerular filtration rate and end-stage kidney disease

35 year 1 with significantly superior estimated glomerular filtration rate and lowest rate of chronic ki

36 Hazard ratios were adjusted for estimated glomerular filtration rate and the components of the CHA

37 s no difference in renal function (estimated glomerular filtration rate and the number of patients al

38 ry were assessed using the average estimated glomerular filtration rate and urinary albumin-to-creati

39 Nephrotic mice displayed decreased glomerular filtration rate and urinary potassium excreti

40 project to identify novel loci for estimated glomerular filtration rate and urine albumin-to-creatini

41 0.038; defined as >25% decrease in estimated glomerular filtration rate) and mortality (hazard ratio,

42 t for demographics, comorbidities, estimated glomerular filtration rate, and enrollment strata.

43 diabetes mellitus, blood pressure, estimated glomerular filtration rate, and hemoglobin).

44 mean serum creatinine, lower mean estimated glomerular filtration rate, and higher area under the cu

45 location was stratified by centre, estimated glomerular filtration rate, and intention to proceed to

46 Full blood count, glomerular filtration rate, and liver function test were

47 endpoints: delayed graft function, estimated glomerular filtration rate, and occult UOC.

48 etes (PTD), cardiac complications, estimated glomerular filtration rate, and occurrence of delayed gr

49 Four patients (5%) had normal glomerular filtration rate, and only one (1%) showed hyp

50 haled nitric oxide use, infection, estimated glomerular filtration rate, and serum bilirubin.

51 dy mass index, smoking, education, estimated glomerular filtration rate, and study center.

52 ulatory support, natriuretic peptide decile, glomerular filtration rate, and total bilirubin level we

53 illation, coronary artery disease, estimated glomerular filtration rate, and urine albumin-to-creatin

54 microalbumin-to- creatinine ratio, estimated glomerular filtration rate, and years of diabetes.

55 tide polymorphisms associated with estimated glomerular filtration rate are located in the SHROOM3 ge

56 ral issues surrounding the donor candidate's glomerular filtration rate assessment.

57 lerosis on delayed graft function, estimated glomerular filtration rate at 1 y, or long-term graft su

58 Glomerular filtration rate at 12 months and rates of bio

59 The median (range) estimated glomerular filtration rate at 2 years posttransplant was

60 Median estimated glomerular filtration rate at 3 months following transpl

61 The decrease of estimated glomerular filtration rate at 5 years post-biopsy was si

62 disease between clusters; however, estimated glomerular filtration rate at baseline was a better pred

63 The co-primary end point of mean estimated glomerular filtration rate at month 12 was 76.2 mL/min/1

64 significant (HR, 2.26; P = 0.015); even when glomerular filtration rate at month 3 < 30 mL/min/1.73 m

65 Mean estimated glomerular filtration rate at month 36 was comparable be

66 eased risk of graft failure, while estimated glomerular filtration rate at time of biopsy (HR, 0.98;

67 nivariate Cox regression analyses, estimated glomerular filtration rate at time of biopsy, glomerulit

68 compared with the mean calculated estimated glomerular filtration rate based on the Modification of

69 compared with the mean calculated estimated glomerular filtration rate based on the Modification of

70 recommended that patients with an estimated glomerular filtration rate below 30 mL/min/1.73 m(2) be

71 e was no significant difference in estimated glomerular filtration rate between CS and MP at 12 month

72 CKD was confirmed by measurements of glomerular filtration rate, blood urea nitrogen, and kid

73 An estimated glomerular filtration rate by chronic kidney disease (CK

74 Measurement of glomerular filtration rate by the plasma clearance of an

75 interaction between treatment and estimated glomerular filtration rate categories for any outcome.

76 isclassified patients according to classical glomerular filtration rate categories in approximately h

77 ge, gender, race, body mass index, estimated glomerular filtration rate, CD4+ T-cell count, antiretro

78 ycosuria without changes in blood glucose or glomerular filtration rate compared with control litterm

79 ster analyses, PENK clustered with estimated glomerular filtration rate, creatinine, NGAL, galectin-3

80 ssification did not associate with estimated glomerular filtration rate decline or graft failure and

81 APOL1-associated estimated glomerular filtration rate decline was observed starting

82 f serum creatinine doubling or 40% estimated glomerular filtration rate decline, kidney failure, or d

83 Adverse events, including estimated glomerular filtration rate decline, were infrequent and

84 mong patients with elevated cfDNA, estimated glomerular filtration rate declined by 8.5% (interquarti

85 Graft survival and estimated glomerular filtration rate determinations at 4 years wer

86 story of premature CAD, age, male sex, lower glomerular filtration rate, diabetes mellitus, elevated

87 across cohorts and subgroups (ie, estimated glomerular filtration rate, diabetes, and sex), but the

88 limus trials (n = 279), decline in estimated glomerular filtration rate did not significantly differ

89 The glomerular filtration rate (e-GFR) was estimated using t

90 participants with normal baseline estimated glomerular filtration rate (eGFR >90 mL/minute/1.73 m2).

91 wiss HIV Cohort Study with a first estimated glomerular filtration rate (eGFR) >60 ml/min/1.73 m2 aft

92 om three groups of recipients: (1) estimated glomerular filtration rate (eGFR) < 30 mL/minute/1.73 m(

93 baseline, 23.8% of patients had an estimated glomerular filtration rate (eGFR) <60 mL.min(-1).1.73 m(

94 hronic kidney disease at baseline (estimated glomerular filtration rate (eGFR) <= 60 mL/min/BSA) (n =

95 Estimated glomerular filtration rate (eGFR) (ml/min/1.73 m(2)) was

96 18-85 years with type 2 diabetes, estimated glomerular filtration rate (eGFR) 25-75 mL/min per 1.73

97 Participants with estimated glomerular filtration rate (eGFR) 59 to 30 mL/min/1.73 m

98 ey outcomes by different levels of estimated glomerular filtration rate (eGFR) and albuminuria.

99 genome-wide association studies of estimated glomerular filtration rate (eGFR) and independent replic

100 all cases, pre- and postope-rative estimated glomerular filtration rate (eGFR) and serum creatinine w

101 of 2 key kidney disease measures, estimated glomerular filtration rate (eGFR) and urinary albumin-to

102 iciency Cohort) study measured the estimated glomerular filtration rate (eGFR) and urine albumin-to-c

103 Estimated glomerular filtration rate (eGFR) as a marker of kidney

104 blood pressure changes and estimated glomerular filtration rate (eGFR) at baseline and 6 mont

105 the 4,953 patients with available estimated glomerular filtration rate (eGFR) at baseline, 1,058 had

106 ne albumin-to-creatinine ratio and estimated glomerular filtration rate (eGFR) based on serum creatin

107 Estimated glomerular filtration rate (eGFR) based on serum creatin

108 using 23 covariates, stratified by estimated glomerular filtration rate (eGFR) before imaging (>=60 m

109 tal kidney volume (TKV) growth and estimated glomerular filtration rate (eGFR) decline over 3 years.

110 th renal function characterised by estimated glomerular filtration rate (eGFR) in a cross-sectional a

111 min-to-creatinine ratio (ACR), and estimated glomerular filtration rate (eGFR) in individuals with ch

112 l can attenuate the decline of the estimated glomerular filtration rate (eGFR) in patients with chron

113 Estimation of glomerular filtration rate (eGFR) in patients with liver

114 lacing serum creatinine (SCr) with estimated glomerular filtration rate (eGFR) in the MELD-Na score m

115 Patients presented with a mean estimated glomerular filtration rate (eGFR) of 13 +/- 11 mL/min/1.

116 grams) of 30 to less than 300, an estimated glomerular filtration rate (eGFR) of 25 to less than 60

117 ary artery) and a creatinine-based estimated glomerular filtration rate (eGFR) of 30-75 ml/min/1.73 m

118 (MACE) in patients with CKD and an estimated glomerular filtration rate (eGFR) of less than 60 ml/min

119 dG were positively associated with estimated glomerular filtration rate (eGFR) over time and a log-un

120 cted individuals but the impact on estimated glomerular filtration rate (eGFR) remains unclear.

121 (AKI) were defined according to an estimated glomerular filtration rate (eGFR) threshold of 90 mL/min

122 We tested three formulae for estimated glomerular filtration rate (eGFR) to determine which was

123 The primary outcome was 12-month estimated glomerular filtration rate (eGFR) using the Chronic Kidn

124 Median estimated glomerular filtration rate (eGFR) was 43.7 ml/min/1.73 m

125 MRI examination were retrieved and estimated glomerular filtration rate (eGFR) was calculated.

126 WHR), body fat (BF) percentage and estimated glomerular filtration rate (eGFR) were identified.

127 additionally adjusted for BMI and estimated glomerular filtration rate (eGFR) were used.

128 We determined baseline estimated glomerular filtration rate (eGFR) with the Chronic Kidne

129 genome-wide association studies of estimated glomerular filtration rate (eGFR), a measure of kidney f

130 associated with pre- and post-TAVR estimated glomerular filtration rate (eGFR), and assess associatio

131 ivity C-reactive protein (hs-CRP), estimated glomerular filtration rate (eGFR), and homeostasis model

132 ding demographics, blood pressure, estimated glomerular filtration rate (eGFR), and proteinuria.

133 hospitalisation for heart failure, estimated glomerular filtration rate (eGFR), body-mass index, and

134 The associations between estimated glomerular filtration rate (eGFR), CFR, diastolic and sy

135 dney disease (CKD), defined by low estimated glomerular filtration rate (eGFR), contributes to global

136 ence of either: >=50% reduction in estimated glomerular filtration rate (eGFR), end-stage renal disea

137 s, hypertension, smoking, lipids, as well as glomerular filtration rate (eGFR), NT-proBNP, interleuki

138 l renal function measures included estimated glomerular filtration rate (eGFR), proteinuria, and bloo

139 graft failure (ACGF) and 12-month estimated glomerular filtration rate (eGFR), respectively.

140 SLK transplant policy change uses estimated glomerular filtration rate (eGFR), which accounts for se

141 isease (CKD), defined by a reduced estimated glomerular filtration rate (eGFR).

142 strong, positive correlation with estimated glomerular filtration rate (eGFR).

143 of SU level on the risk of CKD and estimated glomerular filtration rate (eGFR).

144 according to renal function using estimated glomerular filtration rate (eGFR).

145 the mean (VIM) of creatinine-based estimated glomerular filtration rate (eGFR).

146 ip between plasmin (ogen) uria and estimated glomerular filtration rate (eGFR).

147 ble within 3 months before biopsy (estimated glomerular filtration rate (eGFR): 55.3 +/- 18.9 ml/min/

148 romotryptophan had higher baseline estimated glomerular filtration rate (eGFR, p < 0.001).

149 des correlated negatively with the estimated glomerular filtration rate (eGFR, rho = -0.309, p < 0.00

150 Estimated glomerular filtration rates (eGFR) were assessed by the

151 tus (DM) with or without early DN (estimated glomerular filtration rate [eGFR] >30 mL/min/1.73 m(2)),

152 1 administrations to patients with estimated glomerular filtration rate [eGFR] <30 mL/min per 1.73 m(

153 kidney disease (CKD) at baseline (estimated glomerular filtration rate [eGFR] <60 ml/min/1.73 m(2) o

154 or older) with CKD (defined as an estimated glomerular filtration rate [eGFR] <60 mL/min/1.73 m2 but

155 d kidney function (>=2 measures of estimated glomerular filtration rate [eGFR] <90 mL/min/1.73 m2 >=9

156 easures of chronic kidney disease (estimated glomerular filtration rate [eGFR] and albuminuria) with

157 stained decline of at least 40% in estimated glomerular filtration rate [eGFR] to less than 60 mL/min

158 uded annual HbA1c, renal function (estimated glomerular filtration rate [eGFR]), blood pressure (BP),

159 09 copies/mL with estimated kidney function (glomerular filtration rate, eGFR) and overall survival a

160 n-to-creatinine ratios (UACRs) and estimated glomerular filtration rates (eGFRs) were estimated from

161 fined as at least mildly decreased estimated glomerular filtration rates [eGFRs]).

162 TIMP-2/mOsm before an increase in estimated glomerular filtration rate, enabling us to monitor fDGF

163 All known estimated glomerular filtration rate equations displayed high bias

164 aution when using creatinine based estimated glomerular filtration rate equations.

165 The primary outcome was change in glomerular filtration rate estimated from serum creatini

166 PI and CKiD equations were used to calculate glomerular filtration rate estimates (eGFR).

167 PI and CKiD equations were used to calculate glomerular filtration rate estimates.

168 Glomerular filtration rate estimation by urinary creatin

169 , with dose reduction according to estimated glomerular filtration rate every 4 weeks.

170 s with C-TCMR had >=50% decline in estimated glomerular filtration rate from 3 months compared with 7

171 The adjusted change in mean estimated glomerular filtration rate from baseline to month 6 (Nan

172 versus MAR, within groups with preoperative glomerular filtration rate (GFR) >=60 mL/min/1.73 m; GFR

173 he association between the lower predonation glomerular filtration rate (GFR) and increased ESKD risk

174 Glomerular filtration rate (GFR) and urinary albumin exc

175 dney function was assessed by measurement of glomerular filtration rate (GFR) and urine albumin excre

176 Glomerular filtration rate (GFR) assessment is a key asp

177 Glomerular filtration rate (GFR) assessment is indicated

178 In COMPASS, 21,111 patients had an estimated glomerular filtration rate (GFR) at baseline of >=60 ml/

179 op clinical/protein models to predict future glomerular filtration rate (GFR) deterioration in this p

180 ith allopurinol may slow the decrease in the glomerular filtration rate (GFR) in persons with type 1

181 Evaluation of glomerular filtration rate (GFR) is central to the asses

182 Sustained and rapid loss of glomerular filtration rate (GFR) is the predominant clin

183 Reduction in glomerular filtration rate (GFR) not meeting CKD criteri

184 All the patients had an estimated glomerular filtration rate (GFR) of 30 to <90 ml per min

185 n allowed the accurate quantification of the glomerular filtration rate (GFR) of individual kidneys i

186 Kidney size and glomerular filtration rate (GFR) often increase with the

187 The best glomerular filtration rate (GFR) recovery in survivors w

188 Glomerular filtration rate (GFR) was estimated using the

189 atio of renal oxygen availability (RO(2)) to glomerular filtration rate (GFR), a measure of relative

190 allograft vasculopathy (CAV), improvement in glomerular filtration rate (GFR), and reduced malignancy

191 moking, hypertension, diabetes, cholesterol, glomerular filtration rate (GFR), testosterone, androste

192 hypothyroidism, and normal versus decreased glomerular filtration rate (GFR).

193 nine (SCr)-based calculations for estimating glomerular filtration rate (GFR).

194 th alcohol use disorder (AUD) and comparable Glomerular Filtration Rate (GFR).

195 Primary end point was glomerular filtration rate (GFR).

196 rmality in kidney structure or function (eg, glomerular filtration rate [GFR] <60 mL/min/1.73 m2 or a

197 1) -m in their sensitivity to changes in the glomerular filtration rate, glomerular protein leak, tub

198 Patients with a glomerular filtration rate greater than 60 mL/min/1.73 m

199 In pediatric inpatients with estimated glomerular filtration rate greater than or equal to 60 m

200 lants with atrial fibrillation and estimated glomerular filtration rate >=15 mL/(min.1.73 m(2)) were

201 inine ratio 30 to 5000 mg/g and an estimated glomerular filtration rate >=25 to <75 mL per min per 1.

202 t Association (NYHA) class II-III, estimated glomerular filtration rate >=30 mL/min/1.73m(2), and ele

203 known coronary artery disease, and estimated glomerular filtration rate >=60mL/min/1.73m(2).

204 patients were prescribed a NOAC in estimated glomerular filtration rate >=90, 60 to 90, 45 to 60, 30

205 D-dimer cutoff levels (> 333 ug/L [estimated glomerular filtration rate, > 60 mL/min/1.73 m], > 1,306

206 emia index, increased liver stiffness, lower glomerular filtration rate, higher N-terminal pro-B-type

207 ability to recover 50% of baseline estimated glomerular filtration rate (if not on renal replacement

208 The mean estimated glomerular filtration rate improved from 31.7 +/- 14.2 m

209 th renal function expressed as the estimated glomerular filtration rate in 1540 participants from the

210 cceptable errors when compared with measured glomerular filtration rate in a mixed ICU population, wi

211 was significantly associated with estimated glomerular filtration rate in meta-analysis with replica

212 factor 2 (Nrf2), is effective in increasing glomerular filtration rate in patients with chronic kidn

213 -toxicity, may preserve tubular function and glomerular filtration rate in the long term.

214 in 1 week of treatment, the median estimated glomerular filtration rate increased from 21 to 34 mL/mi

215 of 13 [12-19] mo), the median IQR estimated glomerular filtration rate increased to 52 (46-60) mL/mi

216 We also demonstrated that CRRL269 preserved glomerular filtration rate, increased renal blood flow,

217 ort studies and trials indicate that reduced glomerular filtration rate increases the risk of stroke

218 Prior cerebrovascular events and a low glomerular filtration rate independently predicted the o

219 Additionally, the influence of varying glomerular filtration rates, kidney somatostatin recepto

220 ed for patients who have AKI or an estimated glomerular filtration rate less than 30 mL/min/1.73 m(2)

221 In patients with estimated glomerular filtration rate less than 60 mL/min/1.73 m, t

222 r, had lower lymphocyte counts and estimated glomerular filtration rate levels, and had higher serum

223 ; n = 37) and poor renal function (estimated glomerular filtration rate < 30 mL/min or graft loss at

224 a low kidney function at baseline (estimated glomerular filtration rate < 40 mL/min) was associated w

225 tolic blood pressure <95 mm Hg and estimated glomerular filtration rate <30 mL.min(-1).1.73 m(-2).

226 Estimated glomerular filtration rate <30 mL/min per 1.73 m(2) was

227 of HF patients with advanced CKD (estimated glomerular filtration rate <30 mL/min per 1.73 m(2)) fro

228 en had higher prevalence of hypertension and glomerular filtration rate <30 ml/min/1.73 m(2) but lowe

229 f 6 variables (male sex, diabetes, estimated glomerular filtration rate <30 ml/min/1.73 m(2), Killip

230 factors, including age >60 years, estimated glomerular filtration rate <40 mL.min(-1).1.73 m(-2), an

231 tin (area under the curve [AUC]4.5/AUC5, for glomerular filtration rate <50 mL/min only) administered

232 bserved in 3 populations: baseline estimated glomerular filtration rate <60 mL.min(-1).1.73 m(-2), al

233 Renal dysfunction was defined as estimated glomerular filtration rate <60 mL/min/1.73 m at listing

234 s dipstick proteinuria >=1+ and/or estimated glomerular filtration rate <60 mL/min/1.73 m(2) base on

235 blood pressure, beta-blocker use, estimated glomerular filtration rate <60 mL/min/1.73 m(2), higher

236 D by urinary albumin/creatinine >=30 mg/g or glomerular filtration rate <60 mL/min/1.73 m(2).

237 Incident CKD was defined as an estimated glomerular filtration rate <60 mL/min/1.73 m2 accompanie

238 reduced kidney function threshold (estimated glomerular filtration rate <60 mL/min/1.73 m2 or creatin

239 ients with HFrEF and moderate CKD (estimated glomerular filtration rate <60-30 mL/min per 1.73 m(2)),

240 osite outcome of GF, mortality, or estimated glomerular filtration rate <= 20mL/min/1.73m.

241 t moderate chronic kidney disease (estimated glomerular filtration rate <=45 mL.min(-1).1.73 m(-2)).

242 ic kidney disease (CKD, defined as estimated glomerular filtration rate <=60 mL/min) status.

243 Among 28 patients with estimated glomerular filtration rates <30 mL/min who received >=5

244 the cutoff for administering prophylaxis to glomerular filtration rates <30ml/min/1.73m(2) and elimi

245 expression correlated with reduced estimated glomerular filtration rate (<60 mL/min/1.73 m(2)).

246 Finally, estimated glomerular filtration rate misclassified patients accord

247 red) renal allograft survival with estimated glomerular filtration rates (mL/min per 1.73 m) of 43 to

248 articipants (mean age, 65.9 years; estimated glomerular filtration rate, mL/min per 1.73m(2); hemoglo

249 showed a positive association with estimated glomerular filtration rate (n = 39; r = 0.56; P < .001).

250 onance elastography-derived liver stiffness, glomerular filtration rate, N-terminal pro-B-type natriu

251 dvanced chronic kidney disease (an estimated glomerular filtration rate of <30 ml per minute per 1.73

252 ratio, 2.2; 95% CI, 1.4-3.6; P=0.0012) and a glomerular filtration rate of <30 mL/min per 1.73 m(2) (

253 Nine LD had estimated glomerular filtration rate of <30 mL/min/1.73 m versus 4

254 -dependent chronic kidney disease (estimated glomerular filtration rate of 20-40 mL/min per 1.73 m(2)

255 ine ratio [UACR] 30-3500 mg/g), an estimated glomerular filtration rate of 25-75 mL/min per 1.73 m(2)

256 in-creatinine ratio >300 mg/g, and estimated glomerular filtration rate of 30 to <90 mL/min/1.73 m(2)

257 be considered in patients with an estimated glomerular filtration rate of 30-44 mL/min/1.73 m(2) at

258 nd older, with type 2 diabetes, an estimated glomerular filtration rate of 30-59 mL/min per 1.73 m(2)

259 d risk of 1-year mortality with an estimated glomerular filtration rate of 40 to 60 mL.min(-1).1.73 m

260 ite individuals [82%], with median estimated glomerular filtration rate of 55.8 mL/min/1.73 m2 [IQR,

261 ith a mean age of 62 +/- 13 y old and a mean glomerular filtration rate of 59 +/- 20 mL/min/1.73m.

262 s) with HIV-1 infection who had an estimated glomerular filtration rate of at least 30 mL/min and sen

263 itis B virus infection, and had an estimated glomerular filtration rate of at least 50 mL/min.

264 treated end-stage kidney disease, estimated glomerular filtration rate of less than 15 mL/min per 1.

265 nction remained stable with a mean estimated glomerular filtration rates of 67 +/- 21 and 71 +/- 19 a

266 No changes in estimated glomerular filtration rate or systolic and diastolic blo

267 istory of HF at baseline, baseline estimated glomerular filtration rate or urine albumin-creatinine r

268 onset macroalbuminuria, decline in estimated glomerular filtration rate [or increase in creatinine],

269 >=0.3 mg/dL, or >=25% decrease in estimated glomerular filtration rate, or an increase in cystatin C

270 exol clearance was an estimation of the mean glomerular filtration rate over 24 hours.

271 r heart failure, on the decline in estimated glomerular filtration rate over time, and on the risk of

272 nd poor accuracy when compared with measured glomerular filtration rate, overestimating renal functio

273 peptide), and fibrosis biomarkers; and lower glomerular filtration rate, peak oxygen consumption, 6-m

274 patients without AKI or with high estimated glomerular filtration rate, penKid was associated with h

275 >=90 days of waiting time and CKD (estimated glomerular filtration rate persistently <60 mL/min/1.73

276 r age, sex, race, body mass index, estimated glomerular filtration rate, previous myocardial infarcti

277 (r = 0.47 vs. r = 0.29; Meng test p = 0.07), glomerular filtration rate (r = -0.52 vs. r = -0.24; Men

278 onic variants were associated with estimated glomerular filtration rate (rs58720902 at AQR, minor all

279 The effect on estimated glomerular filtration rate, serum creatinine level, and

280 ident or worsening nephropathy and estimated glomerular filtration rate slope analyses.

281 On average, estimated glomerular filtration rate slope improved postconversion

282 The estimated glomerular filtration rate slope postconversion was comp

283 ) -m excretion with increased single nephron glomerular filtration rate (SNGFR) following unilateral-

284 ter an initial transient decrease, estimated glomerular filtration rate stabilized over time with emp

285 We used estimated glomerular filtration rate trajectories and death-censor

286 age, baseline HbA1c, and baseline estimated glomerular filtration rate), trial duration, treatment d

287 clearance via Cockcroft-Gault and estimated glomerular filtration rate via Modification of Diet in R

288 1.0 years, 50.6% were male, median estimated glomerular filtration rate was 42.3 ml/min/1.73 m2, and

289 The median measured glomerular filtration rate was 51 mL/min/1.73 m (interqu

290 Mean measured glomerular filtration rate was 74.7 mL/min and 62.4 mL/m

291 g the Cockcroft-Gault equation and estimated glomerular filtration rate was calculated using the Modi

292 Baseline estimated glomerular filtration rate was found to be a strong mode

293 In multivariate analysis, only estimated glomerular filtration rate was protective.

294 ey function loss, as determined by estimated glomerular filtration rate, was assessed.

295 ions, patient characteristics, and estimated glomerular filtration rates were abstracted from the VA

296 Clearance factors (e.g. glomerular filtration rate) were significantly associate

297 the association of pre-angiography estimated glomerular filtration rate with adverse outcomes.

298 IV single dose of iohexol and estimation of glomerular filtration rate with creatinine or cystatin C

299 the association of pre-angiography estimated glomerular filtration rate with the primary outcome.

300 association of the pre-angiography estimated glomerular filtration rate with these outcomes.